Janson I M, Toomik R, O'Farrell F, Ek P
Biomedical Centre, Uppsala University, Uppsala, S-751 23, Sweden.
Biochem Biophys Res Commun. 1998 Jun 18;247(2):447-51. doi: 10.1006/bbrc.1998.8809.
The ER retention of lumenal proteins is achieved by a process which involves binding of escaped proteins via the C-terminal KDEL-tags to a KDEL receptor (erd2 receptor) in a post-ER compartment and return of the protein-receptor complex back to the ER. The transmembrane topology of the human KDEL receptor, which is an integral membrane protein, has been proposed. We have synthesised sets of cellulose-bound overlapping peptides covering the complete se quence of the receptor to study the interaction of the erd2 receptor with lumenal ER proteins, CaBP1 and CaBP2. At the next stage, the proposed lumenal loops of the receptor were more closely mapped. A short sequence, essential for the protein binding to the most efficient binding site of the receptor, was identified as 22KIWK25, which is in accordance with one of the proposed structural models of the receptor. The binding was of high specificity and was almost completely inhibited by KDEL-containing soluble peptides. The phosphorylation state of CaBP1/CaBP2 did not affect their binding to the KDEL receptor.
内质网腔蛋白的内质网滞留是通过一个过程实现的,该过程涉及逃逸蛋白通过其C末端的KDEL标签与内质网后区室中的KDEL受体(erd2受体)结合,以及蛋白质-受体复合物返回内质网。人类KDEL受体是一种整合膜蛋白,其跨膜拓扑结构已被提出。我们合成了覆盖该受体完整序列的纤维素结合重叠肽组,以研究erd2受体与内质网腔蛋白CaBP1和CaBP2的相互作用。在下一阶段,对该受体提出的腔环进行了更精确的定位。一个对蛋白质结合到受体最有效结合位点至关重要的短序列被确定为22KIWK25,这与该受体提出的结构模型之一相符。这种结合具有高度特异性,并且几乎完全被含KDEL的可溶性肽抑制。CaBP1/CaBP2的磷酸化状态不影响它们与KDEL受体的结合。